ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer
Franklin C. Harwood(St. Jude Children's Research Hospital), Gerard C. Grosveld(St. Jude Children's Research Hospital), David Finkelstein(St. Jude Children's Research Hospital), Ramon I. Klein Geltink(University of British Columbia), Brendan P. O’Hara(St. Jude Children's Research Hospital), Peter J. Houghton(The University of Texas at San Antonio Health Science Center), Laura J. Janke(St. Jude Children's Research Hospital), Igor Entin(St. Jude Children's Research Hospital), Monica Cardone(St. Jude Children's Research Hospital), Leena Paul(St. Jude Children's Research Hospital)
Cited by 135
Related Papers
The whole-genome landscape of medulloblastoma subtypes
|Nature|2017|1.2k
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
The pediatric preclinical testing program: Description of models and early testing results
|Pediatric Blood & Cancer|2006|486